Hip Replacement Clinical Trials

Clinical trials related to Hip Replacement Procedure

Comparing Collared and Collarless Femoral Stems in Total Hip Arthroplasty

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a prospective randomized control trial comparing two collared and collarless femoral implants used in primary total hip arthroplasty. The specific aims of this trial are to: SA1: Prospectively assess clinical outcomes in patients undergoing primary total hip arthroplasty with a collared versus collarless femoral stem of the same design. SA2: Evaluate serial radiographs to quantify differences in subsidence between collared and collarless implant groups. SA3: Report and compare incidence rates of intraoperative and postoperative periprosthetic fractures and aseptic loosening following primary total hip arthroplasty with use of either a collared or collarless stem. Hypothesis: The addition of a collar to the same designed triple-taper primary hip stem will lead to a reduction in subsidence and incidence of perioperative and periprosthetic femur fractures.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:

• Adults (≥ 18 years old) scheduled for primary, uncemented THA using a cementless femoral stem

• Diagnosis of primary osteoarthritis or other non-inflammatory degenerative joint disease.

• Ability and willingness to comply with study procedures and follow-up schedule.

• Ability to provide written informed consent

Locations
United States
Washington, D.c.
MedStar Georgetown University Hospital
RECRUITING
Washington D.c.
Contact Information
Primary
Miles Hollimon, B.S.
miles.hollimon@medstar.net
(202) 444-8766
Time Frame
Start Date: 2025-12-03
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 100
Treatments
Active_comparator: Collard stem
Active_comparator: Collarless stem
Related Therapeutic Areas
Sponsors
Leads: Medstar Health Research Institute

This content was sourced from clinicaltrials.gov